Basic Information
ID: ALA5223241
Type: Functional
Description: Antiviral activity against SARS-CoV-2 nCoV-2019BetaCoV/Wuhan/WIV04/2019 infected in African green monkey Vero E6 cells assessed as reduction in viral yield in cell supernatant pretreated with cells for 1 hr followed by viral infection for 2 hrs and replacement with fresh medium containing compounds and measured after 24 hrs by plaque assay
Format: BAO_0000218
Organism: Severe acute respiratory syndrome coronavirus 2
Strain: nCoV-2019BetaCoV/Wuhan/WIV04/2019
Cell type: Vero E6
Target: SARS-CoV-2(ALA4303835)
Document: ALA5223064
Antiviral activity against SARS-CoV-2 nCoV-2019BetaCoV/Wuhan/WIV04/2019 infected in African green monkey Vero E6 cells assessed as reduction in viral yield in cell supernatant pretreated with cells for 1 hr followed by viral infection for 2 hrs and replacement with fresh medium containing compounds and measured after 24 hrs by plaque assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA5223241
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 464.50 | 1.86 | 1.86 |
| 452.56 | 2.45 | 2.45 |